A Survey-Based Assessment of United States Clinical Laboratory Response to the 2009 H1N1 Influenza Outbreak

被引:0
|
作者
Hayden, Randall T. [1 ]
Wick, Megan T. [2 ]
Rodriguez, Alicia B. [1 ]
Caliendo, Angela M. [3 ]
Mitchell, Michael J. [4 ]
Ginocchio, Christine C. [5 ]
机构
[1] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA
[2] Coll Amer Pathologists, Northfield, IL USA
[3] Emory Univ Hosp, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[4] UMass Mem Hosp Labs, Worcester, MA USA
[5] N Shore LIJ Hlth Syst Labs, Div Infect Dis Diagnost, Lake Success, NY USA
关键词
HEALTH-CARE INSTITUTIONS; DIRECT FLUORESCENT ASSAY; A H1N1; PERFORMANCE; INFECTION; SEASON; TESTS;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-The recent outbreak of pandemic influenza created enormous economic, logistical, and analytical challenges for clinical laboratories. Laboratory response represented a critical element in the care of affected patients, but little has been published regarding this aspect of the pandemic. Objective.-To assess the overall response of clinical diagnostic laboratories across the United States to the initial phase of the 2009 H1N1 influenza A pandemic. Design.-A 24-question survey was developed and distributed by e-mail to determine current influenza testing practices and how those practices were changed in response to the outbreak of 2009 H1N1 influenza. The survey was distributed to participants in the College of American Pathologists proficiency testing programs related to viral diagnostics. Survey questions focused on laboratory safety, communication of results, testing volume and resources, and whether changes in resource allocation or laboratory practice were anticipated in preparation for the 2009-2010 influenza season. Results.-A total of 24.3% (931) of laboratories responded to the survey. Overall, few laboratories reported changes in methodology in response to the 2009 H1N1 influenza outbreak, although, notably, the number of centers using molecular amplification methods more than doubled, from 41 to 91. Turn-around time for result reporting and safety methods used were largely as expected for individual testing modalities. Shortages in staffing, testing supplies, and personal protective equipment were reported, but most sites were able to maintain operations and did not feel that patient care was negatively affected. Conclusion.-This report provides a comprehensive picture of clinical laboratory responses in the early stages of the 2009 H1N1 influenza pandemic. These data should assist in the continued laboratory management of this outbreak and in planning for future emerging infections. (Arch Pathol Lab Med. 2010; 134: 1671-1678)
引用
收藏
页码:1671 / 1678
页数:8
相关论文
共 50 条
  • [21] 2009 H1N1 Influenza
    Sullivan, Seth J.
    Jacobson, Robert M.
    Dowdle, Walter R.
    Poland, Gregory A.
    MAYO CLINIC PROCEEDINGS, 2010, 85 (01) : 64 - 76
  • [22] 2009 H1N1 Influenza
    Sullivan, Seth J.
    Jacobson, Robert M.
    Dowdle, Walter R.
    Poland, Gregory A.
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2010, 8 (01): : 68 - 80
  • [23] The novel influenza A/H1N1 or (2009) Influenza A/H1N1 or "Swine-origin influenza A (H1N1)"
    Cabezas Fernandez del Campo, Jose Antonio
    ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA, 2009, 75 (04): : 947 - 963
  • [24] 2009 H1N1 Influenza Virus Seroepidemiology Response
    Moattari, Afagh
    IRANIAN JOURNAL OF IMMUNOLOGY, 2010, 7 (02) : 130 - 131
  • [25] Trends of Oseltamivir Usage in the United States During the 2009 Influenza A (H1N1) Pandemic
    Iskander, John K.
    Hales, Craig
    El Bcheraoui, Charbel
    Chen, Robert T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S8 - S9
  • [26] COST-EFFECTIVENESS OF 2009 PANDEMIC INFLUENZA A(H1N1) VACCINATION IN THE UNITED STATES
    Prosser, L. A.
    Lavelle, T. A.
    Fiore, A.
    Bridges, C. B.
    Reed, C.
    Jain, S.
    Dunham, K.
    Meltzer, M.
    VALUE IN HEALTH, 2010, 13 (03) : A192 - A192
  • [27] LABORATORY DIAGNOSIS OF PANDEMIC INFLUENZA A(H1N1) 2009 INFECTION
    Ciblak, Meral Akcay
    Bozkaya, Emel
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2010, 73 (00): : 27 - 33
  • [28] Cost-Effectiveness of 2009 Pandemic Influenza A(H1N1) Vaccination in the United States
    Prosser, Lisa A.
    Lavelle, Tara A.
    Fiore, Anthony E.
    Bridges, Carolyn B.
    Reed, Carrie
    Jain, Seema
    Dunham, Kelly M.
    Meltzer, Martin I.
    PLOS ONE, 2011, 6 (07):
  • [29] Response to the 2009 influenza A(H1N1) pandemic in Italy
    Rizzo, C.
    Rota, M. C.
    Bella, A.
    Giannitelli, S.
    De Santis, S.
    Nacca, G.
    Pompa, M. G.
    Vellucci, L.
    Salmaso, S.
    Declich, S.
    EUROSURVEILLANCE, 2010, 15 (49): : 38 - 45
  • [30] Transmission and control in an institutional pandemic influenza A(H1N1) 2009 outbreak
    Arinaminpathy, N.
    Raphaely, N.
    Saldana, L.
    Hodgekiss, C.
    Dandridge, J.
    Knox, K.
    McCarthy, N. D.
    EPIDEMIOLOGY AND INFECTION, 2012, 140 (06): : 1102 - 1110